Suppr超能文献

前列腺素内过氧化物、血栓素A2和二磷酸腺苷在胶原诱导的兔血小板聚集中的作用

Prostaglandin endoperoxides, thromboxane A2 and adenosine diphosphate in collagen-induced aggregation of rabbit platelets.

作者信息

Lewis G P, Watts I S

出版信息

Br J Pharmacol. 1982 Apr;75(4):623-31. doi: 10.1111/j.1476-5381.1982.tb09183.x.

Abstract

1 A bioassay technique is described for simultaneously monitoring rabbit platelet aggregation with measurement of thromboxane A(2) (TxA(2)) and prostaglandins released in response to collagen or arachidonic acid (AA).2 Five imidazole derivatives were examined as inhibitors of thromboxane synthetase and compared with the effect of the cyclo-oxygenase inhibitor indomethacin; 1-(7-carboxyheptyl) imidazole was identified as the most potent and selective inhibitor of thromboxane synthetase and was used with indomethacin to investigate the relative contribution of the prostaglandin endoperoxides prostaglandin G(2) (PGG(2))/PGH(2) and TxA(2) in mediating platelet aggregation induced by collagen or AA.3 Platelet aggregation induced by a low concentration of collagen was abolished by indomethacin and carboxyheptylimidazole whilst in response to a high concentration or collagen only partial inhibition of aggregation occurred.4 The contribution of adenosine diphosphate (ADP) released from platelets during collagen or AA-induced aggregation was examined using the substrate/enzyme complex creatine phosphate/creatine phosphokinase (CP/CPK). The CP/CPK complex abolished aggregation induced by a low dose of collagen whilst aggregation to a high dose of collagen was only partially inhibited.5 Aggregation induced by a high dose of collagen was abolished by a combination of CP/CPK with indomethacin or carboxyheptylimidazole.6 AA-induced aggregation was abolished by indomethacin. Carboxyheptylimidazole abolished aggregation induced by a low dose of AA but inhibition was surmounted with increasing concentrations of AA in the absence of TxA(2) formation.7 PGH(2)-induced aggregation was unaffected by indomethacin and only partially inhibited by carboxyheptylimidazole. AA or PGH(2)-induced platelet aggregation was unaffected by CP/CPK.8 In conclusion, aggregation of rabbit platelets induced by a low concentration of collagen was dependent on synergism between TxA(2) and ADP whilst at high concentrations of collagen, sufficient TxA(2) and ADP were released to induce aggregation independently of each other.9 The small amounts of prostaglandin endoperoxides produced from endogenous arachidonate have apparently no direct pro-aggregatory role. However, the relatively large amount which can be produced by a high concentration of exogenous AA when TxA(2) formation is prevented can cause aggregation of rabbit platelets.

摘要
  1. 本文描述了一种生物测定技术,可同时监测兔血小板聚集情况,并测定因胶原或花生四烯酸(AA)刺激而释放的血栓素A₂(TxA₂)和前列腺素。

  2. 研究了五种咪唑衍生物作为血栓素合成酶抑制剂的效果,并与环氧化酶抑制剂吲哚美辛的作用进行比较;1-(7-羧基庚基)咪唑被确定为最有效且最具选择性的血栓素合成酶抑制剂,并与吲哚美辛一起用于研究前列腺素内过氧化物前列腺素G₂(PGG₂)/PGH₂和TxA₂在介导胶原或AA诱导的血小板聚集中的相对作用。

  3. 低浓度胶原诱导的血小板聚集被吲哚美辛和羧基庚基咪唑消除,而对高浓度胶原的反应仅出现部分聚集抑制。

  4. 使用底物/酶复合物磷酸肌酸/肌酸磷酸激酶(CP/CPK)研究了胶原或AA诱导聚集过程中血小板释放的二磷酸腺苷(ADP)的作用。CP/CPK复合物消除了低剂量胶原诱导的聚集,而对高剂量胶原诱导的聚集仅部分抑制。

  5. CP/CPK与吲哚美辛或羧基庚基咪唑联合使用可消除高剂量胶原诱导的聚集。

  6. AA诱导的聚集被吲哚美辛消除。羧基庚基咪唑消除了低剂量AA诱导的聚集,但在无TxA₂形成的情况下,随着AA浓度增加抑制作用被克服。

  7. PGH₂诱导的聚集不受吲哚美辛影响,仅被羧基庚基咪唑部分抑制。AA或PGH₂诱导的血小板聚集不受CP/CPK影响。

  8. 总之,低浓度胶原诱导的兔血小板聚集依赖于TxA₂和ADP之间的协同作用,而在高浓度胶原时,释放的TxA₂和ADP足以相互独立地诱导聚集。

  9. 内源性花生四烯酸产生的少量前列腺素内过氧化物显然没有直接的促聚集作用。然而,当TxA₂形成被阻止时,高浓度外源性AA可产生相对大量的前列腺素内过氧化物,从而导致兔血小板聚集。

相似文献

10
Role of thromboxane A2.血栓素A2的作用
Adv Exp Med Biol. 1985;192:293-308. doi: 10.1007/978-1-4615-9442-0_21.

引用本文的文献

本文引用的文献

3
Determination of specific inhibitors of thromboxane A2 formation.血栓素A2生成特异性抑制剂的测定
Br J Pharmacol. 1980 May;69(1):3-5. doi: 10.1111/j.1476-5381.1980.tb10873.x.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验